Table 5
Multiple linear regression analysis with the value of CFVR in the LAD as the dependent variable (r = 0.631, p<0.0001)
| B | 95% CI of B | β | p Value | |
|---|---|---|---|---|
| ACE, angiotensin converting enzyme; ARB, angiotensin II receptor blocker; B, unstandardised regression coefficient; β, standardised coefficient; CI, confidence interval; LVH, left ventricular hypertrophy; SBP, systolic blood pressure. | ||||
| LAD stenosis >50% | −1.070 | −1.242 to −0.898 | −0.570 | <0.0001 |
| Heart rate at rest | −0.014 | −0.021 to −0.007 | −0.181 | 0.0002 |
| LVH | −0.322 | −0.535 to −0.108 | −0.139 | 0.0033 |
| Age | −0.009 | −0.018 to −0.001 | −0.103 | 0.0384 |
| Diabetes | −0.129 | −0.535 to 0.108 | −0.072 | 0.1739 |
| SBP at rest | −0.003 | −0.006 to 0.001 | −0.064 | 0.2120 |
| Smoking | −0.075 | −0.253 to 0.102 | −0.040 | 0.4038 |
| Hypertension | 0.062 | −0.137 to 0.262 | 0.034 | 0.5395 |
| ACE inhibitor or ARB | −0.039 | −0.206 to 0.129 | −0.022 | 0.6495 |
| Hypercholesterolaemia | 0.029 | −0.142 to 0.200 | 0.016 | 0.7415 |
| Nitrate | −0.024 | −0.194 to 0.147 | −0.013 | 0.7826 |
| Calcium inhibitor | 0.012 | −0.176 to 0.200 | 0.007 | 0.8992 |
| Myocardial infarct in the LAD | −0.011 | −0.209 to 0.188 | −0.005 | 0.9166 |
| Male sex | 0.006 | −0.181 to 0.192 | 0.003 | 0.9537 |
